Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome

Kidney International

Volumn 67, Issue 1, 2005, Pages 122-129

  Holt, Richard C L ^a   Webb, Nicholas J A ^a   Ralph, Shirley ^a   Davies, John ^a   Short, Colin D ^a   Brenchley, Paul B C ^a  

^a NONE

Author keywords

Heparanase; Proteinuria; Steroid sensitive nephrotic syndrome

Indexed keywords

CREATININE; HEPARANASE; MESSENGER RNA; PROTEOHEPARAN SULFATE;

ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 10944255514     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00062.x     Document Type: Article

References (40)

1. BROYER M, MEYRIER A, NIAUDET P, HABIB R: Minimal change disease and focal segmental sclerosis, in Oxford Textbook of Clinical Nephrology, 2nd ed., 1998
2. BRENCHLEY P: Vascular permeability factors in steroid sensitive nephrotic syndrome and focal segmental glomerulonephritis. Nephrol Dial Transplant 18 (Suppl 6): 18-25, 2003
3. DANIELS BS, SALANT DJ, QUIGG RJ, CYBULSKY AV: The role of the glomerular epithelial cell in the maintenance of the glomerular filtration barrier. Intern Med 13:318-323, 1993
4. KANWAR YS, ROSENZWEIG LJ: Altered glomerular permeability as a result of focal detachment of the visceral epithelium. Kidney Int 21:565-574, 1982
5. TRYGGVASON K, RUOTSALAINEN V, WARTIOVAARA J: Discovery of the congenital nephrotic syndrome gene discloses the structure of the mysterious molecular sieve of the kidney. Int J Dev Biol 43:445-451, 1999
6. SALANT DJ, QUIGG RJ, CYBULSKY AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35:976-984, 1989
7. KANWAR YS, LINKER A, FARQUHAR MG: Anionic sites in the glomerular basement membrane. In vivo and in vitro localisation to the lamina rarae by cationic probes. J Cell Biol 81:137-153, 1979
8. KOSHY V, AVASTHI PS: The anionic sites at luminal surface of peritubular capillaries. Kidney Int 31:52-58, 1987
9. KANWAR YS: Biology of disease: Biophysiology of glomerular filtration and proteinuria. Lab Invest 18:42-48, 1984
10. THOMAS GJ, JENNER L, MASON RM, et al: Human glomerular epithelial cell proteoglycans. Arch Biochem Biophys 278:11-20, 1990
11. GROFFEN AJ, RUEGG MA, DIJKMAN H, et al: Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 46:19-27, 1998
12. KLEIN DJ, BROWN DM, OEGEMA TR, et al: Glomerular basement membrane proteoglycans are derived from a large precursor. J Cell Biol 106:963-970, 1988
13. Iozzo RV, COHEN IR, GRASSEL S, MURDOCH AD: The biology of perlecan: The multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices, Biochem J 302:625-639, 1994
14. OKADA Y, YAMADA S, TOYOSHIMA M, et al: Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. J Biol Chem 277:42488-42495, 2002
15. VLODAVSKY I, FRIEDMANN Y, ELKIN M, et al: Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802, 1999
16. HULETT MD, FREEMAN C, HAMDORF BJ, et al: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5:803-809, 1999
17. DEMPSEY LA, BRUNN GJ, PLATT JL: Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25:349-351, 2000
18. HAIMOV-KOCHMAN R, FRIEDMANN Y, PRUS D, et al: Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod 8:566-573, 2002
19. VLODAVSKY I, ELDOR A, HAIMOVITZ-FRIEDMAN A, et al: Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112-127, 1992
20. HERSHKOVIZ R, MOR F, MIAO HQ, et al: Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity. J Autoimmunity 8:741-750, 1995
21. GOLDSHMIDT O, ZCHARIA E, ABRAMOVITCH R, et al: Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 99:10031-10036, 2002
22. KANWAR YS, LINKER A, FARQUHAR MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 86:688-693, 1980
23. DANIELS BS: Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. J Lab Clin Med 124:224-230, 1994
24. RAATS CJI, BARKER MAH, VANDENBORN J, BERDEN JHM: Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 272:26734-26741, 1997
25. VAN DEN BORN J, VAN DEN HEUVAL LP, BARKER MA, et al: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115-123, 1992
26. LEVIDIOTIS V, KANELLIS J, IERINO FL, POWER DA: Increased expression of heparanase in puromycin aminonucleoside nephrosis. Kidney Int 60:1287-1296, 2001
27. LEVIDIOTIS V, FREEMAN C, TIKELLIS C, et al: Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. J Am Soc Nephrol 15:68-78, 2004
28. KATZ A, VAN DIJK DJ, AINGORN H, et al: Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Israel Med Assoc J 4:996-1002, 2002
29. BEHZAD F, BRENCHLEY PEC: A multiwell format assay for heparanase. Analytical Biochemistry 320:207-213, 2003
30. SEWELL RF, BRENCHLEY PE, MALLICK NP: Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J 264:777-783, 1989
31. SEWELL RF, SHORT CD: Minimal-change nephropathy: How does the immune system affect the glomerulus? Nephrol Dial Transplant 8:108-112, 1993
32. GONZALEZ-STAWINSKI GV, PARKER W, HOLZKNECHT ZE, et al: Partial sequence of human platelet heparitinase and evidence of its ability to polymerize. Bba Protein Struct Mol Enzym 1429:431-438, 1999
33. TOYOSHIMA M, NAKAJIMA M: Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274:24153-24160, 1999
34. XIAOTONG H, BRENCHLEY P, JAYSON G, et al: Hypoxia increases heparanase dependent tumour cell invasion which can be inhibited by anti-heparanase antibodies. Cancer Res 64:3928-3933, 2004
35. GILAT D, HERSHKOVIZ R, GOLDKORN I, et al: Molecular behavior adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH. J Exp Med 181:1929-1934, 1995
36. GOLDSHMIDT O, ZCHARIA E, COHEN M, et al: Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J 17:1015-1025, 2003
37. DEMPSEY LA, PLUMMER TB, COOMBES SL, PLATT JL: Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 10:467-475, 2000
38. NADAV L, ELDOR A, YACOBY-ZEEVI O, et al: Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 115:2179-2187, 2002
39. PARISH CR, FREEMAN C, BROWN KJ, et al: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59:3433-3441, 1999
40. ZCHARIA E, METZGER S, CHAJEK-SHAUL T, et al: Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 18:252-263, 2004